Home > Boards > US Listed > Biotechs > REATA PHARMACEUTICALS INC [ RETA ] (RETA)

8-O

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Cbdpotential Member Profile
 
Followed By 251
Posts 16,054
Boards Moderated 1
Alias Born 03/28/13
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/19/2019 4:07:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2019 3:03:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2019 2:19:39 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/13/2019 5:07:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 4:14:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 4:09:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/13/2019 4:06:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 4:05:01 PM
Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Bardoxolone Methyl for the Treatment of Autosomal Dominant P... GlobeNewswire Inc. - 6/5/2019 6:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2019 1:12:02 PM
Reata Announces Presentations at the 56th Congress of the European Renal Association and European Dialysis and Transplant As... GlobeNewswire Inc. - 6/4/2019 7:00:00 PM
Reata Announces First Patient Enrolled in Phase 3 FALCON Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant ... GlobeNewswire Inc. - 5/30/2019 6:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/17/2019 11:48:09 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 6:57:18 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 6:50:40 AM
Reata Pharmaceuticals, Inc. Announces First Quarter 2019 Financial Results and an Update on Development Programs GlobeNewswire Inc. - 5/9/2019 6:45:00 AM
Reata Announces Presentation at the Annual CKD3 Chronic Kidney Disease Drug Development Summit GlobeNewswire Inc. - 5/2/2019 4:15:00 PM
Reata Pharmaceuticals, Inc. to Report First Quarter 2019 Financials and to Provide an Update on Development Programs on May 9... GlobeNewswire Inc. - 5/2/2019 6:45:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/30/2019 6:51:22 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 6:28:49 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/16/2019 2:21:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2019 5:25:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/21/2019 3:25:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/19/2019 5:33:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/7/2019 5:58:04 PM
Cbdpotential   Monday, 11/14/16 01:37:09 PM
Re: None
Post # of 37 
8-O

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist